We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 7,841

LYRICA: Timing of a PBS Application
  • Wrays
  • Australia
  • February 27 2017

The recent decision of Apotex Pty Ltd v Warner-Lambert Company LLC (No 3) 2017 FCA 94 (Apotex No 3) highlights the importance of the timing of an


Life Sciences: Product Regulation and Liability in Denmark
  • Gorrissen Federspiel
  • Denmark, Global
  • February 24 2017

A structured guide to product regulation and liability laws in Denmark


The importance of Swiss-style claims in Australia
  • Shelston IP Lawyers Pty Ltd
  • Australia
  • February 24 2017

As reported previously, the Federal Court (Nicholas J) confirmed in Apotex Pty Ltd v Warner-Lambert Company LLC (No 3) 2017 FCA 94 that offers made


Availability of non-infringing product is relevant in determining profit recovery for infringing activities
  • McCarthy Tétrault LLP
  • Canada
  • February 24 2017

In a recent decision (Apotex Inc. v. ADIR, 2017 FCA 23), the Federal Court of Appeal determined that the Federal Court erred in law by rejecting the


Editing the future: A brief introduction to CRISPR
  • Allen & Overy LLP
  • USA
  • February 23 2017

For those with an interest in life sciences, the rise to prominence of CRISPR has been impossible to ignore. It seems a day does not go by without


Matching Claim Language with Label Language Ensnares Infringers
  • Knobbe Martens Olson & Bear LLP
  • USA
  • February 23 2017

On January 12, 2017, the U.S. Court of Appeals for the Federal Circuit issued an opinion affirming the judgement that Eli Lilly’s U.S. Patent No. 7


Quantity Trumps Quality: Supreme Court Decides Life Technologies v. Promega
  • Banner & Witcoff Ltd
  • USA
  • February 23 2017

The question before the Supreme Court in this case was simple: did the Federal Circuit err when it decided that shipment outside the United States of


Supreme Court Limits 271(f)(1) Overseas Infringement Reach: More than One Exported Component Required for Offshore Manufacturing Liability
  • Eversheds Sutherland (US) LLP
  • USA
  • February 23 2017

The US Supreme Court held in Life Techs. Corp. v. Promega Corp., Slip No. 14-1538 (Feb. 22, 2017) that supplying a single component of a


Does A Recent Cert Grant Open A New Front In the Patent Venue War?
  • Squire Patton Boggs
  • USA
  • February 22 2017

Broad patent venue rules allowing corporations to be sued for patent infringement almost anywhere are under siege both in Congress and in the courts


Trial decision awaited on 'Arrow declarations'
  • Taylor Wessing
  • United Kingdom
  • February 22 2017

In the Fujifilm Kyowa Kirin Biologics Co. Ltd & Anor (FKB) v AbbVie Biotechnology Ltd litigation, FKB has filed two claims (FKB1 and FKB2) to obtain